151 related articles for article (PubMed ID: 20154208)
1. Small-molecule inhibitors of vascular adhesion protein-1 reduce the accumulation of myeloid cells into tumors and attenuate tumor growth in mice.
Marttila-Ichihara F; Castermans K; Auvinen K; Oude Egbrink MG; Jalkanen S; Griffioen AW; Salmi M
J Immunol; 2010 Mar; 184(6):3164-73. PubMed ID: 20154208
[TBL] [Abstract][Full Text] [Related]
2. Vascular adhesion protein-1 enhances tumor growth by supporting recruitment of Gr-1+CD11b+ myeloid cells into tumors.
Marttila-Ichihara F; Auvinen K; Elima K; Jalkanen S; Salmi M
Cancer Res; 2009 Oct; 69(19):7875-83. PubMed ID: 19789345
[TBL] [Abstract][Full Text] [Related]
3. Function-blocking antibodies to human vascular adhesion protein-1: a potential anti-inflammatory therapy.
Kirton CM; Laukkanen ML; Nieminen A; Merinen M; Stolen CM; Armour K; Smith DJ; Salmi M; Jalkanen S; Clark MR
Eur J Immunol; 2005 Nov; 35(11):3119-30. PubMed ID: 16224816
[TBL] [Abstract][Full Text] [Related]
4. SSAO inhibitors suppress hepatocellular tumor growth in mice.
Li R; Li H; Luo HJ; Lin ZX; Jiang ZW; Luo WH
Cell Immunol; 2013; 283(1-2):61-9. PubMed ID: 23850964
[TBL] [Abstract][Full Text] [Related]
5. Ischemia-reperfusion injury is attenuated in VAP-1-deficient mice and by VAP-1 inhibitors.
Kiss J; Jalkanen S; Fülöp F; Savunen T; Salmi M
Eur J Immunol; 2008 Nov; 38(11):3041-9. PubMed ID: 18991279
[TBL] [Abstract][Full Text] [Related]
6. Endothelial amine oxidase AOC3 transiently contributes to adaptive immune responses in the airways.
Dunkel J; Aguilar-Pimentel JA; Ollert M; Fuchs H; Gailus-Durner V; de Angelis MH; Jalkanen S; Salmi M; Veres TZ
Eur J Immunol; 2014 Nov; 44(11):3232-9. PubMed ID: 25116373
[TBL] [Abstract][Full Text] [Related]
7. Vascular adhesion protein-1 and ICAM-1 support the adhesion of tumor-infiltrating lymphocytes to tumor endothelium in human hepatocellular carcinoma.
Yoong KF; McNab G; Hübscher SG; Adams DH
J Immunol; 1998 Apr; 160(8):3978-88. PubMed ID: 9558106
[TBL] [Abstract][Full Text] [Related]
8. VCAM-1 and VAP-1 recruit myeloid cells that promote pulmonary metastasis in mice.
Ferjančič Š; Gil-Bernabé AM; Hill SA; Allen PD; Richardson P; Sparey T; Savory E; McGuffog J; Muschel RJ
Blood; 2013 Apr; 121(16):3289-97. PubMed ID: 23407548
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of vascular adhesion protein-1 enhances the anti-tumor effects of immune checkpoint inhibitors.
Kinoshita T; Sayem MA; Yaguchi T; Kharma B; Morii K; Kato D; Ohta S; Mashima Y; Asamura H; Kawakami Y
Cancer Sci; 2021 Apr; 112(4):1390-1401. PubMed ID: 33453147
[TBL] [Abstract][Full Text] [Related]
10. Cloning and characterization of mouse vascular adhesion protein-1 reveals a novel molecule with enzymatic activity.
Bono P; Salmi M; Smith DJ; Jalkanen S
J Immunol; 1998 Jun; 160(11):5563-71. PubMed ID: 9605161
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte binding to vascular endothelium in inflamed skin revisited: a central role for vascular adhesion protein-1 (VAP-1).
Arvilommi AM; Salmi M; Kalimo K; Jalkanen S
Eur J Immunol; 1996 Apr; 26(4):825-33. PubMed ID: 8625974
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity.
O'Rourke AM; Wang EY; Miller A; Podar EM; Scheyhing K; Huang L; Kessler C; Gao H; Ton-Nu HT; Macdonald MT; Jones DS; Linnik MD
J Pharmacol Exp Ther; 2008 Feb; 324(2):867-75. PubMed ID: 17993604
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of vascular adhesion protein-1 suppresses endotoxin-induced uveitis.
Noda K; Miyahara S; Nakazawa T; Almulki L; Nakao S; Hisatomi T; She H; Thomas KL; Garland RC; Miller JW; Gragoudas ES; Kawai Y; Mashima Y; Hafezi-Moghadam A
FASEB J; 2008 Apr; 22(4):1094-103. PubMed ID: 18032635
[TBL] [Abstract][Full Text] [Related]
14. The role of two distinct endothelial molecules, vascular adhesion protein-1 and peripheral lymph node addressin, in the binding of lymphocyte subsets to human lymph nodes.
Salmi M; Hellman J; Jalkanen S
J Immunol; 1998 Jun; 160(11):5629-36. PubMed ID: 9605169
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice.
Wang SH; Yu TY; Tsai FC; Weston CJ; Lin MS; Hung CS; Kao HL; Li YI; Solé M; Unzeta M; Chen YL; Chuang LM; Li HY
Transl Res; 2018 Jul; 197():12-31. PubMed ID: 29653075
[TBL] [Abstract][Full Text] [Related]
16. A peptide inhibitor of vascular adhesion protein-1 (VAP-1) blocks leukocyte-endothelium interactions under shear stress.
Yegutkin GG; Salminen T; Koskinen K; Kurtis C; McPherson MJ; Jalkanen S; Salmi M
Eur J Immunol; 2004 Aug; 34(8):2276-85. PubMed ID: 15259025
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic advantage of anti-VAP-1 over anti-α4 integrin antibody in concanavalin a-induced hepatitis.
Lee WY; Salmi M; Kelly MM; Jalkanen S; Kubes P
Hepatology; 2013 Oct; 58(4):1413-23. PubMed ID: 23686782
[TBL] [Abstract][Full Text] [Related]
18. Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression.
Dirkx AE; Oude Egbrink MG; Kuijpers MJ; van der Niet ST; Heijnen VV; Bouma-ter Steege JC; Wagstaff J; Griffioen AW
Cancer Res; 2003 May; 63(9):2322-9. PubMed ID: 12727857
[TBL] [Abstract][Full Text] [Related]
19. Homing of mucosal leukocytes to joints. Distinct endothelial ligands in synovium mediate leukocyte-subtype specific adhesion.
Salmi M; Rajala P; Jalkanen S
J Clin Invest; 1997 May; 99(9):2165-72. PubMed ID: 9151788
[TBL] [Abstract][Full Text] [Related]
20. FLT3 ligand administration inhibits tumor growth in murine melanoma and lymphoma.
Esche C; Subbotin VM; Maliszewski C; Lotze MT; Shurin MR
Cancer Res; 1998 Feb; 58(3):380-3. PubMed ID: 9458075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
